These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32867720)

  • 1. Urine concentration ability is reduced to the same degree in adult dominant polycystic kidney disease compared with other chronic kidney diseases in the same CKD-stage and lower THAN in healthy control subjects - a CASE control study.
    Malmberg MH; Mose FH; Pedersen EB; Bech JN
    BMC Nephrol; 2020 Aug; 21(1):379. PubMed ID: 32867720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion.
    Graffe CC; Bech JN; Lauridsen TG; Pedersen EB
    Am J Physiol Renal Physiol; 2012 Apr; 302(8):F917-27. PubMed ID: 22262484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of Urine Dilution Ability between Adult Dominant Polycystic Kidney Disease, Other Chronic Kidney Diseases, and Healthy Control Subjects: A Case-Control Study.
    Malmberg MH; Mose FH; Pedersen EB; Bech JN
    Int J Nephrol; 2020; 2020():4108418. PubMed ID: 33343937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tolvaptan on renal handling of water and sodium, GFR and central hemodynamics in autosomal dominant polycystic kidney disease during inhibition of the nitric oxide system: a randomized, placebo-controlled, double blind, crossover study.
    Al Therwani S; Malmberg MES; Rosenbaek JB; Bech JN; Pedersen EB
    BMC Nephrol; 2017 Aug; 18(1):268. PubMed ID: 28810844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal function of the vasopressin-cyclic-AMP-aquaporin2 axis during urine concentrating and diluting in patients with reduced renal function. A case control study.
    Pedersen EB; Thomsen IM; Lauridsen TG
    BMC Nephrol; 2010 Oct; 11():26. PubMed ID: 20923561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.
    Zittema D; Boertien WE; van Beek AP; Dullaart RP; Franssen CF; de Jong PE; Meijer E; Gansevoort RT
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):906-13. PubMed ID: 22516290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.
    Zittema D; Casteleijn NF; Bakker SJ; Boesten LS; Duit AA; Franssen CF; Gaillard CA; Gansevoort RT
    PLoS One; 2017; 12(1):e0169263. PubMed ID: 28081165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal urinary excretion of NKCC2 and AQP2 in response to hypertonic saline in chronic kidney disease: an intervention study in patients with chronic kidney disease and healthy controls.
    Jensen JM; Mose FH; Kulik AE; Bech JN; Fenton RA; Pedersen EB
    BMC Nephrol; 2014 Jun; 15():101. PubMed ID: 24970686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal increase in urinary aquaporin-2 excretion in response to hypertonic saline in essential hypertension.
    Graffe CC; Bech JN; Lauridsen TG; Vase H; Pedersen EB
    BMC Nephrol; 2012 Mar; 13():15. PubMed ID: 22452789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct effect of methylprednisolone on renal sodium and water transport via the principal cells in the kidney.
    Lauridsen TG; Vase H; Bech JN; Nielsen S; Pedersen EB
    Eur J Endocrinol; 2010 May; 162(5):961-9. PubMed ID: 20203161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of volume expansion with hypertonic- and isotonic saline and isotonic glucose on sodium and water transport in the principal cells in the kidney.
    Jensen JM; Mose FH; Bech JN; Nielsen S; Pedersen EB
    BMC Nephrol; 2013 Sep; 14():202. PubMed ID: 24067081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of Proximal Tubular Secretion in Autosomal Dominant Polycystic Kidney Disease.
    Wang K; Zelnick LR; Chen Y; Hoofnagle AN; Watnick T; Seliger S; Kestenbaum B
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):80-88. PubMed ID: 31628117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of hypervolemia on electrolyte level and and level of volume regulating hormones in patients with autosomal dominant polycystic kidney disease].
    Michalski A; Grzeszczak W
    Pol Arch Med Wewn; 1996 Oct; 96(4):329-43. PubMed ID: 9082344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased renal sodium absorption by inhibition of prostaglandin synthesis during fasting in healthy man. A possible role of the epithelial sodium channels.
    Lauridsen TG; Vase H; Starklint J; Graffe CC; Bech JN; Nielsen S; Pedersen EB
    BMC Nephrol; 2010 Oct; 11():28. PubMed ID: 21029429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
    Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
    Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal dominant polycystic kidney disease is associated with central and nephrogenic defects in osmoregulation.
    Ho TA; Godefroid N; Gruzon D; Haymann JP; Maréchal C; Wang X; Serra A; Pirson Y; Devuyst O
    Kidney Int; 2012 Nov; 82(10):1121-9. PubMed ID: 22718190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an acute oral ibuprofen intake on urinary aquaporin-2 excretion in healthy humans.
    Pedersen RS; Bentzen H; Bech JN; Pedersen EB
    Scand J Clin Lab Invest; 2001; 61(8):631-40. PubMed ID: 11768323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
    Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 3% saline and furosemide on biomarkers of kidney injury and renal tubular function and GFR in healthy subjects - a randomized controlled trial.
    Mose FH; Jörgensen AN; Vrist MH; Ekelöf NP; Pedersen EB; Bech JN
    BMC Nephrol; 2019 Jun; 20(1):200. PubMed ID: 31159750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of potassium supplementation on renal tubular function, ambulatory blood pressure and pulse wave velocity in healthy humans.
    Matthesen SK; Larsen T; Vase H; Lauridsen TG; Pedersen EB
    Scand J Clin Lab Invest; 2012 Feb; 72(1):78-86. PubMed ID: 22149452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.